Drugs

Optimum Bronchodilator Combinations in Chronic Obstructive Pulmonary Disease: What is the Current Evidence?
pp. 301-308(8)
Authors: Miles, Matthew C.; Donohue, James F.; Ohar, Jill. A.

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents
pp. 309-325(17)
Authors: Childress, Ann C.; Berry, Sally A.

Erratum
pp. 326-326(1)

Pharmacokinetics of Intravenous Ibuprofen: Implications of Time of Infusion in the Treatment of Pain and Fever
pp. 327-337(11)
Authors: Smith, Howard S.; Voss, Bryan

Antibacterials as Adjuncts to Incision and Drainage for Adults with Purulent Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections
pp. 339-351(13)
Authors: Forcade, Nicolas A.; Wiederhold, Nathan P.; Ryan, Laurajo; Talbert, Robert L.; Frei, Christopher R.

Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
pp. 353-360(8)
Author: Keating, Gillian M.

Azithromycin 1.5% Ophthalmic Solution: In Purulent Bacterial or Trachomatous Conjunctivitis
pp. 361-373(13)
Author: Garnock-Jones, Karly P.

Tapentadol Extended Release: In Adults with Chronic Pain
pp. 375-393(19)
Author: Hoy, Sheridan M.

Budesonide/Formoterol Turbuhaler®: A Review of its Use in Chronic Obstructive Pulmonary Disease
pp. 395-414(20)
Author: Scott, Lesley J.

Romiplostim: A Review of its Use in Immune Thrombocytopenia
pp. 415-435(21)
Author: Keating, Gillian M.